撤稿：血浆白细胞介素-35升高作为局限性透明细胞肾细胞癌的预后指标
Retracted: Elevated Plasma Interleukin-35 as a Prognostic Indicator in Localized Clear Cell Renal Cell Carcinoma.
作者信息
And Alternative Medicine Evidence-Based Complementary
出版信息
Evid Based Complement Alternat Med. 2023 Jun 21;2023:9846548. doi: 10.1155/2023/9846548. eCollection 2023.
Abstract
[This retracts the article DOI: 10.1155/2022/6886590.].
摘要
[本文撤回文章DOI: 10.1155/2022/6886590。]
相似文献
1
Retracted: Elevated Plasma Interleukin-35 as a Prognostic Indicator in Localized Clear Cell Renal Cell Carcinoma.撤稿：血浆白细胞介素-35升高作为局限性透明细胞肾细胞癌的预后指标
Evid Based Complement Alternat Med. 2023 Jun 21;2023:9846548. doi: 10.1155/2023/9846548. eCollection 2023.
2
Retracted: Identification of Differentially Methylated Genes Associated with Clear Cell Renal Cell Carcinoma and Their Prognostic Values.撤回：与透明细胞肾细胞癌相关的差异甲基化基因的鉴定及其预后价值。
J Environ Public Health. 2023 Dec 13;2023:9756067. doi: 10.1155/2023/9756067. eCollection 2023.
3
Retracted: Integrated Analysis of the Roles of RNA Binding Proteins and Their Prognostic Value in Clear Cell Renal Cell Carcinoma.撤回：RNA结合蛋白在透明细胞肾细胞癌中的作用及其预后价值的综合分析
J Healthc Eng. 2023 May 24;2023:9828737. doi: 10.1155/2023/9828737. eCollection 2023.
4
Retracted: A New Survival Model Based on Cholesterol Biosynthesis-Related Genes for Prognostic Prediction in Clear Cell Renal Cell Carcinoma.撤回：一种基于胆固醇生物合成相关基因的新生存模型用于透明细胞肾细胞癌的预后预测
Biomed Res Int. 2024 Mar 20;2024:9838460. doi: 10.1155/2024/9838460. eCollection 2024.
5
Elevated Plasma Interleukin-35 as a Prognostic Indicator in Localized Clear Cell Renal Cell Carcinoma.血浆白细胞介素-35升高作为局限性透明细胞肾细胞癌的预后指标
Evid Based Complement Alternat Med. 2022 Sep 10;2022:6886590. doi: 10.1155/2022/6886590. eCollection 2022.
6
Retracted: Comprehensive Analysis of Regulatory Network for LINC00472 in Clear Cell Renal Cell Carcinoma.撤回：肾透明细胞癌中LINC00472调控网络的综合分析。
J Healthc Eng. 2023 Oct 4;2023:9864232. doi: 10.1155/2023/9864232. eCollection 2023.
7
Retracted: Comprehensive Analysis of the Expression and Prognosis for E2Fs in Human Clear Cell Renal Cell Carcinoma.撤回：人透明细胞肾细胞癌中E2F的表达与预后综合分析
J Healthc Eng. 2022 Nov 27;2022:9807439. doi: 10.1155/2022/9807439. eCollection 2022.
8
Retracted: A Novel Biomarker, FKBP10, for Poor Prognosis Prediction in Patients with Clear Cell Renal Cell Carcinoma.撤回：一种用于预测透明细胞肾细胞癌患者预后不良的新型生物标志物FKBP10 。
Evid Based Complement Alternat Med. 2023 Oct 4;2023:9780837. doi: 10.1155/2023/9780837. eCollection 2023.
9
Retracted: Clinical Study on the Efficacy of Microwave Ablation (MA) in the Treatment of Stage I Renal Clear Cell Carcinoma by CT and MRI Imaging.撤稿：通过CT和MRI成像对微波消融（MA）治疗I期肾透明细胞癌疗效的临床研究。
J Healthc Eng. 2023 Jul 12;2023:9862864. doi: 10.1155/2023/9862864. eCollection 2023.
10
Retracted: Screening of Differentially Expressed Iron Death-Related Genes and the Construction of Prognosis Model in Patients with Renal Clear Cell Carcinoma.撤回：肾透明细胞癌患者中差异表达的铁死亡相关基因筛选及预后模型构建
Comput Math Methods Med. 2023 Oct 18;2023:9823636. doi: 10.1155/2023/9823636. eCollection 2023.
本文引用的文献
1
Elevated Plasma Interleukin-35 as a Prognostic Indicator in Localized Clear Cell Renal Cell Carcinoma.血浆白细胞介素-35升高作为局限性透明细胞肾细胞癌的预后指标
Evid Based Complement Alternat Med. 2022 Sep 10;2022:6886590. doi: 10.1155/2022/6886590. eCollection 2022.
Zotero 插件